BACKGROUND An enhanced understanding of Parkinson’s disease (PD) in recent years has led to the revelation that the motor symptoms by which we’ve been defining and describing PD are late-stage, downstream consequences of a degenerative process decades in the making. The objective outcome measures traditionally used in clinic and PD research rely heavily on motor symptoms and have been shown to lack sensitivity early in the disease. The Patient-Reported Outcomes in PD (PRO-PD) scale is an entirely subjective, patient-centered tool designed to be useful to patients, providers, and researchers as a remote patient monitoring system. OBJECTIVE The goal was to create a continuous outcome measure that does not require a clinic visit, is sensitive early in the disease, does not fluctuate throughout the day, captures severity of both motor and non-motor symptoms, and correlates with quality of life (QoL) and existing measures of severity. METHODS Two datasets were used with a total of 13,349 participants with PRO-PD scores. Data quality, feasibility, Cronbach’s alpha, and confirmatory factor analysis was conducted. Longitudinal analysis to determine change over time was completed. Response to change was evaluated by initiation of levodopa. RESULTS The PRO-PD scale shows acceptable validity with a 95.1% completion rate, non-significant floor and ceiling effects, acceptable skew and kurtosis, Cronbach’s alpha of >0.75 for the total scale and subscales with acceptable unidimentionality (r between 0.37 and 0.84). Confirmatory factor analysis (CFI = 0.841, Tucker Lewis Index = 0.829, SRMSEA = 0.054) shows room for improvement for factors. Responsiveness has been shown by mean change per year in PRO-PD score of 38 (±14) and significant improvement in PRO-PD score with initiation of dopamine replacement therapy. CONCLUSIONS These analyses suggest the PRO-PD is a feasible and valid tool for remote patient monitoring in PD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.